Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
9.29
-0.48 (-4.91%)
Mar 31, 2025, 1:15 PM EDT - Market open
Tyra Biosciences Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$30.50
Upside
+228.31%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +222.93% | Mar 31, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +222.93% | Feb 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +222.93% | Jan 13, 2025 |
UBS | UBS | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +201.40% | Jan 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $30 | Strong Buy | Maintains | $32 → $30 | +222.93% | Nov 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +244.46% | Oct 29, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +244.46% | Oct 28, 2024 |
Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +201.40% | Oct 25, 2024 |
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $22 → $31 | Hold → Strong Buy | Upgrades | $22 → $31 | +233.69% | Oct 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +222.93% | Oct 7, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $25 → $33 | Buy | Maintains | $25 → $33 | +255.22% | Sep 19, 2024 |
Piper Sandler | Piper Sandler | Buy Initiates $33 | Buy | Initiates | $33 | +255.22% | Aug 15, 2024 |
Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +201.40% | Aug 8, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $28 → $25 | Buy | Maintains | $28 → $25 | +169.11% | Aug 8, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $28 | Buy | Reiterates | $28 | +201.40% | Jul 3, 2024 |
Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +201.40% | Jul 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.